Literature DB >> 350130

The hypothalamus in Parkinson disease.

J W Langston, L S Forno.   

Abstract

The hypothalamus was systematically examined in 30 patients with pathologically documented idiopathic parkinsonism. Using Lewy body formation as a marker for nerve cell degeneration, we observed abnormalities in every hypothalamus examined. Of the thirteen hypothalamic nuclei that could be individually identified, none were exempt from Lewy body degeneration. The tuberomamillary nucleus and the lateral and posterior hypothalamic nuclei demonstrated the highest average Lewy body counts (16, 9, and 3, respectively); they were also the most frequently involved nuclei. These findings may aid in interpretation of the autonomic and endocrine abnormalities in patients with Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350130     DOI: 10.1002/ana.410030207

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  66 in total

1.  Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.

Authors:  Maren C Locke; Samuel S Wu; Kelly D Foote; Marco Sassi; Charles E Jacobson; Ramon L Rodriguez; Hubert H Fernandez; Michael S Okun
Journal:  Neurosurgery       Date:  2011-05       Impact factor: 4.654

Review 2.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

Review 3.  Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Authors:  J M Pavon; H E Whitson; M S Okun
Journal:  Maturitas       Date:  2010-02-01       Impact factor: 4.342

4.  Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons.

Authors:  Sarah A McClymont; Paul W Hook; Alexandra I Soto; Xylena Reed; William D Law; Samuel J Kerans; Eric L Waite; Nicole J Briceno; Joey F Thole; Michael G Heckman; Nancy N Diehl; Zbigniew K Wszolek; Cedric D Moore; Heng Zhu; Jennifer A Akiyama; Diane E Dickel; Axel Visel; Len A Pennacchio; Owen A Ross; Michael A Beer; Andrew S McCallion
Journal:  Am J Hum Genet       Date:  2018-11-29       Impact factor: 11.025

5.  Suppressed sympathetic skin response in Parkinson disease.

Authors:  T H Haapaniemi; J T Korpelainen; U Tolonen; K Suominen; K A Sotaniemi; V V Myllylä
Journal:  Clin Auton Res       Date:  2000-12       Impact factor: 4.435

6.  Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease.

Authors:  G Meco; L Pratesi; V Bonifati
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

7.  Determinants of autonomic dysfunction in idiopathic Parkinson's disease.

Authors:  Alexei Korchounov; Kirn R Kessler; Nikolay N Yakhno; Igor V Damulin; Hayo I Schipper
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 8.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

9.  A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.

Authors:  M Yoshita; J Taki; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

10.  Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome.

Authors:  W R Gibb; D N Griffith
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.